RHY 15.6% $1.11 rhythm biosciences limited

Other research in this space, page-3

  1. 172 Posts.
    lightbulb Created with Sketch. 34
    Globally there’s unsurprisingly a heap going on in this space, and there’s several blood based tests already commercially available, each with their pros and cons. As outlined the the prospectus (I think, or at least in an annual) Colostat will fit into a niche because it will be considerably cheaper than most of these and can slot into an elisa assay without the need for new lab equipment. It’s brilliant in concept. We just need to get the bloody thing to market.
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Mkt cap ! $224.4M
Open High Low Value Volume
98.0¢ $1.13 98.0¢ $1.194M 1.133M

Buyers (Bids)

No. Vol. Price($)
1 3656 $1.09

Sellers (Offers)

Price($) Vol. No.
$1.12 4000 2
View Market Depth
Last trade - 16.10pm 18/05/2021 (20 minute delay) ?
0.150 ( 14.6 %)
Open High Low Volume
98.0¢ $1.12 98.0¢ 48036
Last updated 15.54pm 18/05/2021 (live) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.